We are live on ! Find out more
ME

McIlrath & Eck Portfolio holdings

AUM $1.35B
1-Year Est. Return 15.78%
This Fund
S&P 500
This Quarter Est. Return
+6.13%
1 Year Est. Return
+15.78%
3 Year Est. Return
+43.95%
5 Year Est. Return
+48.52%
10 Year Est. Return
AUM
$208M
AUM Growth
+$19.1M
Cap. Flow
+$8.01M
Cap. Flow %
3.84%
Top 10 Hldgs %
84.52%
Holding
684
New
34
Increased
115
Reduced
75
Closed
28

Sector Composition

Rank Sector Weight
1 Technology 11.12%
2 Financials 2.19%
3 Communication Services 1.61%
4 Consumer Discretionary 1.59%
5 Consumer Staples 1.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROAN
676
DELISTED
Roan Resources, Inc.
ROAN
-40
Closed
STI
677
DELISTED
SunTrust Banks, Inc.
STI
-28
Closed -$2K
AABA
678
DELISTED
Altaba Inc
AABA
-312
Closed -$6K
MFGP
679
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$0 ﹤0.01%
29
-113
-80% -$1.56K
WLL
680
DELISTED
Whiting Petroleum Corporation
WLL
0
FTR
681
DELISTED
Frontier Communications Corp.
FTR
$0 ﹤0.01%
4
CELG
682
DELISTED
Celgene Corp
CELG
-488
Closed -$48K
AUO
683
DELISTED
AU Optronics Corp
AUO
-143
Closed
GCI
684
DELISTED
Gannett Co., Inc
GCI
-25
Closed

Similar funds

McIlrath & Eck's Q4 2019 Portfolio in Review

As of Q4 2019, McIlrath & Eck held 684 positions worth $208M, up 10% from $189M the previous quarter. Its ten largest holdings account for 85% of the portfolio.

McIlrath & Eck deployed $8.01M of net new capital in Q4 2019, opening 34 new positions and adding to 115 existing holdings. Its largest new stake was iShares Biotechnology ETF: 512 shares worth $62K.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 8.5% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Vanguard Morningstar Growth ETF, an estimated $452K trimmed.

  • McIlrath & Eck's largest Q4 2019 buy was iShares Biotechnology ETF: 512 shares worth $62K.
  • McIlrath & Eck added most to Microsoft in Q4 2019, an estimated $3.95M increase.
  • McIlrath & Eck's biggest Q4 2019 reduction was Vanguard Morningstar Growth ETF, cutting an estimated $452K.
  • McIlrath & Eck fully exited Celgene Corp in Q4 2019, selling an estimated $48K.
  • McIlrath & Eck's ten largest holdings make up 85% of its $208M portfolio in Q4 2019.
  • McIlrath & Eck opened 34 new positions and closed 28 in Q4 2019.
  • McIlrath & Eck's portfolio value rose 10% quarter-over-quarter to $208M.

Based on McIlrath & Eck's 13F filing for Q4 2019, filed 11 Feb 2020.